Roles of Macrophage Polarization and Macrophage-Derived miRNAs in Pulmonary Fibrosis

Amit Kishore1,2, Martin Petrek1,3,4

  • 1Department of Pathological Physiology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia.

Frontiers in Immunology
|September 7, 2021
PubMed

Insights

Macrophage polarization (M1/M2) influences inflammation and fibrosis in interstitial lung disease. Targeting macrophage-derived microRNAs (miRNAs) offers a promising therapeutic strategy for pulmonary fibrosis.

Area of Science:

  • Immunology
  • Pulmonary Medicine
  • Cell Biology

Background:

  • Interstitial lung disease (ILD), particularly pulmonary fibrosis, involves complex inflammatory and immune responses.
  • Macrophage activation and polarization are critical regulators of these responses in the fibrosing lung.
  • Specific macrophage phenotypes, M1 (pro-inflammatory) and M2 (pro-fibrogenic), play distinct roles in disease pathogenesis.

Purpose of the Study:

  • To review the current evidence on macrophage polarization in interstitial lung disease.
  • To elucidate the role of M1 and M2 macrophages in regulating inflammatory and fibrogenic mediators.
  • To explore the involvement of macrophage-derived microRNAs (miRNAs) in the progression of pulmonary fibrosis.

Main Methods:

  • Literature review of studies investigating macrophage polarization in pulmonary fibrosis.
  • Analysis of research on M1/M2 macrophage phenotypes and their associated mediators.
  • Examination of the role of cellular and exosomal microRNAs in macrophage-driven fibrosis.

Main Results:

  • Polarized M1/M2 macrophage populations regulate inflammatory and fibrogenic mediators in pulmonary fibrosis.
  • M1 macrophages are associated with pro-inflammatory signatures, while M2 macrophages exhibit pro-fibrogenic signatures.
  • Macrophage-derived microRNAs (miRNAs), including exosomal miRNAs from M2 macrophages, contribute to the development and progression of lung fibrosis.

Conclusions:

  • Macrophage polarization is a key factor in the pathogenesis of pulmonary fibrosis.
  • Macrophage-derived miRNAs are significant regulators of fibrotic processes.
  • Targeting microRNAs involved in macrophage polarization presents a potential therapeutic avenue for pulmonary fibrosis.